Role of TGFβ1 in Modulating Lipid Profile in Patients with Hashimoto's Thyroiditis
DOI:
https://doi.org/10.46966/msjar.v4i3.146Keywords:
TGFβ1, Hashimoto's Thyroiditis, Lipid profileAbstract
Background:Hashimoto's thyroiditis, an autoimmune condition primarily affecting the thyroid gland, leads to persistent inflammation and impaired thyroid function. Conversely, transforming growth factor beta-1 (TGF-β1) is a crucial protein that regulates various cellular processes, including immune responses and tissue remodeling. Present research aimed to explore the correlation between TGFβ-1 levels in Hashimoto's Thyroiditis (HT) patients and their lipid profile levels, to achieve this. Method: A case-control study involved 90 female participants aged 20-53 years, comprising diagnosed Hashimoto's thyroiditis patients, and an equal number of age and gender-matched healthy volunteers. The levels of TGF–β1, T3, T4, TSH, fT3, fT4, Anti TPO, Anti-TG, were investigated using the ELISA method. Moreover, the study groups' analysis included measuring, cholesterol, TG, LDL, HDL, and vLDL using specific commercial kits. Result: The findings revealed a highly significant variation in TGFβ1 levels between the HT patients group and healthy group, highlighting the potential role of TGF-β1 in Hashimoto's thyroiditis.emia as compared with healthy group.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Niran Noori Abed , Prof. Dr. Elham Abed Mahdi
This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
